Advertisement

Topics

James Mapes to Lead Navigant Cymetrix

08:30 EST 8 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Experienced senior executive selected to drive growth for the comprehensive revenue cycle management provider Navigant (NYSE:NCI) announces that James “Jim” Mapes has joined Navigant as a key member of its healthcare pra...

Other Sources for this Article

Navigant Investor Relations
Aaron Miles, 312.583.5820
aaron.miles@navigant.com
or
Navigant Corporate Communications
Belia Ortega, 312.583.2640
belia.ortega@navigant.com

NEXT ARTICLE

More From BioPortfolio on "James Mapes to Lead Navigant Cymetrix"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...